leisure time -WSS

leisure time

author：entertainment 2025-09-29 18:17:13 - browse：2534

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Beyond aggravation: Constipation is an American epidemic

WSS

Living organ donors deserve priority status for transplants

Congress: Prevent baby formula shortages by passing a new bill

A public health expert passes on football's full body collisions for youths

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Can medical device makers keep up in the race to treat obesity?

Should insurance cover cosmetic surgery?

focus

leisure time

hotspot

At least 13 dead in Texas as scorching temps continue

Novo pauses ads for weight loss drug Wegovy amid demand

Medical leaders decry Supreme Court decision on affirmative action

Inside the rise of 'mukbang' eating videos

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Hospitals need to get ahead of regulations on climate change

The high cost of giving birth even with insurance

The Bio Revolution is changing business and society

Novavax promises a turnaround & Lilly roils the obesity market

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

explore

The world needs the new pandemic treaty

Decentralized clinical trials need collaboration to achieve wider use

Unmasking the 'centricity' illusion in clinical trials

Bird flu makes raw milk dangerous to consume, mouse study finds

Achieving telehealth equity for people with hearing loss

Some medical students still think black patients feel less pain

hotspot

focus

hotspot

entertainment